Markus Luber
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Renal Transplantation Outcomes and Treatments 3
-
- IL-33, ST2, and ILC Pathways 3
- Psoriasis: Treatment and Pathogenesis 2
- Co-authors
- Georg Andreas Schett (5 shared papers)Andreas Ramming (4 shared papers)Jörg Distler (4 shared papers)Oliver Distler (2 shared papers)Christina Bergmann (2 shared papers)Clara Dees (2 shared papers)Rudolf Jaenisch (1 shared paper)Yun Zhang (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (2 papers)Journal of Clinical Investigation (1 paper)Nature Medicine (1 paper)iScience (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Markus Luber
11 papers receiving 679 citations
Peers
Comparison fields: 5 of 61
- Rheumatology 174
- Immunology 194
- Pathology and Forensic Medicine 85
- Rehabilitation 23
- Hepatology 27
Countries citing papers authored by Markus Luber
This map shows the geographic impact of Markus Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Luber more than expected).
Fields of papers citing papers by Markus Luber
This network shows the impact of papers produced by Markus Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Luber. The network helps show where Markus Luber may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Luber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 247 | |
| 2 | 2019 | 158 | |
| 3 | 2020 | 113 | |
| 4 | 2018 | 77 | |
| 5 | 2019 | 43 | |
| 6 | 2021 | 37 | |
| 7 | 2021 | 6 | |
| 8 | 2026 | 4 | |
| 9 | 2020 | 1 | |
| 10 | 2021 | 1 | |
| 11 | 2026 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2026 | 0 |
About Markus Luber
Markus Luber is a scholar working on Transplantation, Immunology, Pathology and Forensic Medicine, Rheumatology and Hepatology, having authored 13 papers that have together received 688 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (3 papers), Renal Transplantation Outcomes and Treatments (3 papers), IL-33, ST2, and ILC Pathways (3 papers), TGF-β signaling in diseases (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Liver physiology and pathology (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Rheumatology (174 citations), Immunology (194 citations), Pathology and Forensic Medicine (85 citations), Rehabilitation (23 citations) and Hepatology (27 citations). Markus Luber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Georg Andreas Schett, Andreas Ramming, Jörg Distler, Oliver Distler, Christina Bergmann, Clara Dees, Rudolf Jaenisch, Yun Zhang, Kolja Gelse and Xiang Zhou. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of Clinical Investigation, Nature Medicine, iScience and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.